Positron emission tomography (PET) in oncology
A Gallamini, C Zwarthoed, A Borra - Cancers, 2014 - mdpi.com
Since its introduction in the early nineties as a promising functional imaging technique in the
management of neoplastic disorders, FDG-PET, and subsequently FDG-PET/CT, has …
management of neoplastic disorders, FDG-PET, and subsequently FDG-PET/CT, has …
Role of functional imaging in the management of lymphoma
BD Cheson - Journal of Clinical Oncology, 2011 - ascopubs.org
18-F-fluorodeoxyglucose (FDG)–positron emission tomography (PET), and more recently
PET/computed tomography (CT), is the most sensitive and specific imaging technique …
PET/computed tomography (CT), is the most sensitive and specific imaging technique …
Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group
Purpose Recent advances in imaging, use of prognostic indices, and molecular profiling
techniques have the potential to improve disease characterization and outcomes in …
techniques have the potential to improve disease characterization and outcomes in …
Revised response criteria for malignant lymphoma
BD Cheson, B Pfistner, ME Juweid… - Journal of clinical …, 2007 - ascopubs.org
Purpose Standardized response criteria are needed to interpret and compare clinical trials
and for approval of new therapeutic agents by regulatory agencies. Methods The …
and for approval of new therapeutic agents by regulatory agencies. Methods The …
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the …
Background The intensive polychemotherapy regimen eBEACOPP (bleomycin, etoposide,
doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone in escalated …
doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone in escalated …
Early Interim 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage …
Purpose Starting from November 2001, 260 newly diagnosed patients with Hodgkin's
lymphoma (HL) were consecutively enrolled in parallel Italian and Danish prospective trials …
lymphoma (HL) were consecutively enrolled in parallel Italian and Danish prospective trials …
[BOOK][B] Khan's Treatment Planning in Radiation Oncology:.
FM Khan, PW Sperduto, JP Gibbons - 2021 - books.google.com
Offering comprehensive coverage of the clinical, physical, and technical aspects of radiation
treatment planning, Khan's Treatment Planning in Radiation Oncology, Fifth Edition …
treatment planning, Khan's Treatment Planning in Radiation Oncology, Fifth Edition …
Omitting radiotherapy in early positron emission tomography–negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: clinical …
JMM Raemaekers, MPE Andre, M Federico… - Journal of clinical …, 2014 - ascopubs.org
Purpose Combined-modality treatment is standard treatment for patients with clinical stage
I/II Hodgkin lymphoma (HL). We hypothesized that an early positron emission tomography …
I/II Hodgkin lymphoma (HL). We hypothesized that an early positron emission tomography …
Positron emission tomography–guided treatment in early-stage favorable Hodgkin lymphoma: final results of the international, randomized phase III HD16 trial by the …
M Fuchs, H Goergen, C Kobe, G Kuhnert… - Journal of clinical …, 2019 - ascopubs.org
PURPOSE Combined-modality treatment (CMT) with 2× ABVD (doxorubicin, bleomycin,
vinblastine, and dacarbazine) and small-field radiotherapy is standard of care for patients …
vinblastine, and dacarbazine) and small-field radiotherapy is standard of care for patients …
International validation study for interim PET in ABVD-treated, advanced-stage Hodgkin lymphoma: interpretation criteria and concordance rate among reviewers
At present, there are no standard criteria that have been validated for interim PET reporting
in lymphoma. In 2009, an international workshop attended by hematologists and nuclear …
in lymphoma. In 2009, an international workshop attended by hematologists and nuclear …